Français
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
metrorrhagia/triglyceride
Le lien est enregistré dans le presse-papiers
15 résultats
Premenopause contraception with monthly injectable Mesigyna with special emphasis on serum lipid and bone density patterns.
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
This 2-year study compared Mesigyna(R) administered to 49 pre-menopausal women between 38 and 50 years, to 99 women fitted with an IUD (Nova-T). A complete lipoprotein assessment was carried out before treatment and at 6, 12, and 24 months of treatment. A bone densitometry was performed on half of
Clinical comparison of triphasic norgestimate/35 micrograms ethinyl estradiol and monophasic norethindrone acetate/20 micrograms ethinyl estradiol. Cycle control, lipid effects, and user satisfaction.
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
This six-cycle, multicenter, open-label, randomized study compared the clinical experience of two low-dose oral contraceptives (OC): a triphasic OC containing norgestimate (NGM) and 35 micrograms ethinyl estradiol (EE) (Ortho Tri-Cyclen) and a monophasic OC containing norethindrone acetate (NETA)
Twelve years of clinical experience with an oral contraceptive containing 30 micrograms ethinyloestradiol and 150 micrograms desogestrel.
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
The clinical experience with a combined oral contraceptive (COC) containing 150 micrograms desogestrel and 30 micrograms ethinylestradiol is reviewed. Fourteen clinical trials have been reported involving over 44,000 women for more than 190,000 cycles. None of the 17 pregnancies which occurred
A randomized study of metabolic effects of four low-estrogen oral contraceptives: I. Results after 6 cycles.
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
Healthy, non-smoking, normotensive, well-motivated young women were assigned at random to one of four different, commercial, low-estrogen, oral contraceptive products. Measurements of biochemical parameters were made on blood specimens collected from fasting subjects twice during the late
A randomized prospective study of the metabolic effects of four low-estrogen oral contraceptives.
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
Healthy, nonsmoking, normotensive, well-motivated young women were assigned at random to one of four different commercial, low-estrogen oral contraceptives. Measurements of biochemical parameters were made on two blood specimens collected from fasting subjects late in the pretreatment cycle, then
Clinical evaluation of a new combined oral contraceptive desogestrel--ethinylestradiol.
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
A clinical study was performed with a new progestogen, desogestrel, in a 0.15 mg dose associated with 0.03 mg of ethinylestradiol and was administered cyclically during 21 days; 632 cycles were evaluated in 56 women. Side-effects were scarce and generally of a mild nature. Monthly bleeding was
[Estradiol valerate/cyproterone acetate in the treatment of climacteric syndrome].
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
In a prospective study 40 perimenopausal women with climacteric complaints between 45 to 52 years of age were examined. Twenty three (100%) were assigned to treatment with hormonal replacement therapy (Climen fy Schering-estradiol valerate cyproteron acetate) for 6 months. The therapy had to be
[A prospective study of nylestriol on plasma lipids in postmenopausal women].
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
A prospective, double-blind clinical study has been carried out in 90 chinese women with postmenopausal period covering 0.5 to 21 years by administering a synthetic long-acting estriol derivative-nylestriol in the regimen of 2 mg every 2 weeks for 1 year (49 treated and 41 placebo). The result were:
Sequential estrogen-progestin addition to gonadotropin-releasing hormone agonist suppression for the chronic treatment of ovarian hyperandrogenism: a pilot study.
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
The purpose of the study was to evaluate the efficacy and safety of a sequential regimen of estrogen-progestin addition to GnRH agonist suppression in ovarian hyperandrogenism. Eight patients presenting with a polycystic ovary syndrome were treated with an sc implant of GnRH agonist every 4 weeks
Benefits of vaginal estriol cream combined with clonidine HCL for menopausal syndrome treatment.
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
In a group of 25 post menopausal women mean age 57.2 years, treatment with Estriol vagina cream (Ovestin cream from Organon-Holland) gives rise (but within normal limits) to cholesterol, triglycerides and HDL-cholesterol, the protective factor against M. I. A rise in glycohemoglobin (HbA1C)
A transdermal regimen for continuous combined hormone replacement therapy in the menopause.
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
Transdermal systems for oestrogen therapy in the menopause have become very popular. The compliance, however, is impeded by the cyclic addition of oral progestins which leads to monthly withdrawal bleeds. In this pilot study a skin patch releasing 0.05 mg oestradiol and 0.25 mg norethisterone
[Indicators of lipid metabolism and aminotransferase activity in girls with dysfunctional uterine hemorrhage].
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
In a study of 42 girls, aged 12 to 15 years, including 27 patients with dysfunctional uterine bleedings (DUB) and 15 normal controls, the levels of glucose, total lipids, beta-lipoproteins, total cholesterol, as well as beta-lipoprotein, triglycerides, nonesterified fatty acid (NEFA) cholesterol and
Evaluation of a combined oral contraceptive pill in black Zimbabwean women.
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
A prospective exploratory study was carried out on lipid metabolism (41 women); as well as efficacy, acceptability and safety on another 190 women who all were using a combined oral contraceptive pill (OC) containing 30 micrograms Ethinyl oestradiol and 150mg Desogestrel (Marvelon) over a period of
Clinical experience and pharmacological effects of an oral contraceptive containing 20 micrograms oestrogen.
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
The performance of a new low-dose oral contraceptive (Mercilon) containing only 20 micrograms ethinyloestradiol combined with 150 micrograms desogestrel is reviewed. Eight multicentre clinical trials have been completed and provide information on 10,672 women studied over 73,477 cycles. The high
Thyroid Symptomatology across the Spectrum of Hypothyroidism and Impact of Levothyroxine Supplementation in Patients with Severe Primary Hypothyroidism.
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
La base de données d'herbes médicinales la plus complète soutenue par la science
- Fonctionne en 55 langues
- Cures à base de plantes soutenues par la science
- Reconnaissance des herbes par image
- Carte GPS interactive - étiquetez les herbes sur place (à venir)
- Lisez les publications scientifiques liées à votre recherche
- Rechercher les herbes médicinales par leurs effets
- Organisez vos intérêts et restez à jour avec les nouvelles recherches, essais cliniques et brevets
Tapez un symptôme ou une maladie et lisez des informations sur les herbes qui pourraient aider, tapez une herbe et voyez les maladies et symptômes contre lesquels elle est utilisée.
* Toutes les informations sont basées sur des recherches scientifiques publiées
